InvestSMART

Algorae Pharmaceuticals Limited (ASX:1AI)

ALERT: Price-sensitive ASX Announcement for 1AI
Current share price for 1AI : $0.011 0.001 (10%)+
Announcement
Release
1 Jul 2026 9:03AM
Price at Release
$0.010
Full Release
download
Summary
Algorae Pharmaceuticals Limited, an AI-enabled pharmaceutical company, announced that it has been awarded a contract by NSW Health to supply public hospitals, following a competitive tender process. The initial contract has a three-year term, with two optional one-year extensions. Although the exact financial terms are confidential, the revenue will be incorporated into the company's total product revenue. This contract marks a significant milestone in Algorae's commercial strategy, validating its market approach and paving the way for future growth. Algorae also focuses on combining AI-driven drug discovery with pharmaceutical commercialization, utilizing its proprietary platform AlgoraeOS to predict drug synergies.
Key Points
  • Algorae awarded a NSW Health public hospital supply contract.
  • Initial contract term of three years, with two optional one-year extensions.
  • Contract terms are confidential; revenue recognized within product revenue.
  • The award validates Algorae's strategy and commercial capabilities.
  • Algorae's dual strategy includes AI-driven drug discovery and commercialization.
  • AlgoraeOS platform predicts synergistic drug combinations.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.